RADL3Raia Drogasil S.A.Company Data · 1T26updated 2026-08-24
1
Overview
4T11 — 1T26 · 50 quarters
▼
Raia Drogasil S.A.
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
SectorComércio (Atacado e Varejo)
Company HeadquartersSão Paulo, SP
Full Time Employees75.190
CEOMr. Renato Cepollina Raduan
Listing SegmentNovo Mercado
Foundation1935
Customer Rating—
Employee Rating—
Estrutura Acionária
68%Free Float
Wells Holding Limited11%
Gl Investimentos e Participacoes Ltda6%
Capital Research Global Investors ("CRGI")(Gestor/Administrador - Vide item 6.6 a seguir)6%
Rbc Global Asset Management Inc. (Gestor/Administrador - Vide Item 6.6 A Seguir)5%
BlackRock, Inc. (Gestor/Administrador - Vide item 6.6 a seguir)5%
Free Float68%
Valuation
| Price | R$ 18,43 |
| Shares Outstanding | 1.748.536 |
| Market Capitalization | 32.226 |
| ( - ) Cash & Equivalents | 538 |
| ( + ) Total Debt | 3.662 |
| ( = ) Enterprise Value | 35.349 |
| P/E | 27,6x |
| EV / EBITDA | 7,7x |
R$ 18,43
Adj close · daily
Income Statement
| Revenue | 42.716 |
| EBITDA | 4.591 |
| EBIT | 2.502 |
| Net Income | 1.169 |
| SG&A % | (23,9%) |
Balance Sheet
| Assets | 25.272 |
| Cash | 538 |
| Total Debt | 3.662 |
| Net Debt | 3.124 |
| Fixed Assets | 9.314 |
| Working Capital | 5.806 |
| Equity | 7.340 |
Invested Capital & Reinvestment
| Invested Capital Turnover | 3,02x |
| Marginal IC Turnover | 1,01x |
| Reinvestment % NOPAT | 17,2% |
| Working Capital Turnover | 8,38x |
| Cash Conv. Cycle | 60,0 |
| Fixed Assets Turnover | 4,73x |
| D&A % Fixed Assets | 23,6% |
| Capex % Revenue | 2,9% |
15,8 %
RoIC · LTM
RoIC (LTM)
Margins & Returns
| Revenue Growth | 9,9% |
| Gross Margin | 29,9% |
| EBITDA Margin | 10,8% |
| Net Income Margin | 2,7% |
| Effective Tax Rate | 8,1% |
| Operating Leverage | 0,64x |
| RoIC | 15,8% |
| RoE | 17,0% |
Capital Structure
| Current Ratio | 1,47x |
| Financial Leverage | 3,44x |
| Asset Turnover | 1,80x |
| Net Debt / EBITDA | 0,68x |
| Net Debt & Lease / EBITDA | 1,78x |
Cash Flow
| CFO Conversion | 69,6% |
| FCFF Yield | 4,2% |
| FCFE Yield | 2,9% |
| Payout Ratio | 26,4% |
| Dividend Yield | 0,7% |
| Interest % FCFF | 21,1% |
Latest CVM filings
- 2026-05-05reported 1T26
- 2025-11-04reported 3T25
- 2025-08-05reported 2T25
- 2025-05-06reported 1T25